COVID-19 Immunity May Shield Against Future SARS-Type Pandemics
Global immunity developed through COVID-19 infection and vaccination may offer significant protection against other viruses in the SARS family, potentially lowering the risk of future coronavirus pandemics, according to new research led by the MRC-University of Glasgow Centre for Virus Research (CVR). The study, published in Nature Communications, suggests that widespread immunity to SARS-CoV-2 has created a “biological barrier” against related viruses.
Broad Immunity Beyond SARS-CoV-2
Researchers combined patient antibody samples with mathematical modeling to examine levels of immunity against SARS-type viruses in the general population. They discovered that, in addition to strong immunity to SARS-CoV-2, individuals also possessed immunity against a range of “sarbecoviruses”—the broader family to which SARS-CoV-2 belongs. This indicates that exposure to SARS-CoV-2, whether through infection or vaccination, generates a broader immune response than previously understood.
A ‘Biological Barrier’ to Emerging Threats
According to Pablo Murcia, professor of integrative virology at the CVR, “Our global experience with COVID-19 has generated a biological barrier to other coronaviruses.” While not guaranteeing immunity to all future threats, the study suggests that existing immunity has made it more tricky for other sarbecoviruses to initiate a new pandemic. The research indicates that the circulation of SARS-CoV-2, coupled with global vaccination efforts, has created an “immunity shield” against the emergence of novel sarbecoviruses in humans.
Potential for Existing Vaccines to Combat New Variants
The study also suggests that current COVID-19 vaccines could play a crucial role in slowing or stopping the spread of any potential new sarbecovirus, dubbed “SARS-CoV-X.” Brian Willett, professor of viral immunology at the CVR, explained that mathematical models indicate existing vaccines could be effective against emerging coronaviruses. He emphasized that rapid implementation of vaccination programs following the identification of a new sarbecovirus would be most beneficial, while delays could reduce effectiveness.
Understanding Sarbecoviruses and the CVR’s Research
The MRC-University of Glasgow Centre for Virus Research (CVR) is dedicated to understanding SARS-CoV-2 and developing strategies to combat it. Their research focuses on various aspects of the virus, including its structure, origin, and the emergence of new variants. Recent operate by the CVR has also revealed how SARS-CoV-2 can evolve differently in various parts of the body during long-term infections, highlighting the complexity of viral evolution. This research developed a new method to study virus evolution in long-term COVID-19 infections.
Implications for Pandemic Preparedness
These findings offer a hopeful perspective on future pandemic preparedness. The development of broad immunity through existing COVID-19 vaccines and infections may provide a crucial head start in mitigating the impact of emerging sarbecoviruses. Continued research and monitoring of viral evolution will be essential to maintain this protective barrier and ensure a swift response to any future threats.
This research was funded by the UKRI Medical Research Council (MRC) and the UKRI Biotechnology and Biological Sciences Research Council (BBSRC).